Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen - Wikidata - wikimedia - TriplyDB

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen

http://www.wikidata.org/entity/Q34622938

about

Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it Hypothesis: lipoprotein(a) is a surrogate for ascorbate The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.Apolipoprotein (a) concentrations and susceptibility to coronary artery disease in patients with peripheral vascular disease.Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis.Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.Expressed hypervariable polymorphism of apolipoprotein (a).Fibrin, lipoprotein(a), plasmin interactions: a model linking thrombosis and atherogenesis.Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a)Lipoprotein(a) and its role in occlusive vascular disease.Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.Lipoprotein (a). Heterogeneity and biological relevance.Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome?Critical review of non-statin treatments for dyslipoproteinemia.Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).Lipoprotein(a): searching for a function.Lipoprotein (a): Coming of Age at Last.Structure, function, and genetics of lipoprotein (a).Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles.Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a).Lipoprotein(a) enhances plasma clot lysis in vitro.Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin Characterization of the enzyme activity of human plasma lipoprotein (a) using synthetic peptide substrates.

P2860

Q24305939-DB137771-7483-40F9-8672-DFF493FBFEB1 Q24557502-1F0D3384-8CBA-4A2A-A2C6-6B8756FCF945 Q24562140-58794820-0873-4DDA-A82F-B2DE37AEC5E1 Q24669902-BFBBE854-50AA-4540-8849-630C959BB7E1 Q24792333-EE2C0071-6FC1-4AE5-995E-867559DCEB4A Q24796498-F8EC5D72-639F-4C35-BB08-42D43F13CA40 Q33563669-9E8695D1-CB03-4E44-82C0-1C015CA4769D Q33612119-BC5FBF77-2D1B-4483-8B63-19410C953774 Q33859197-7B0DCB76-7F9F-4015-8683-6C445399106A Q34092208-A3B4DC53-E271-4B78-B0F0-8B3264DB13D4 Q34118495-F6AF2952-6578-4182-AFFA-8DC29E2C7427 Q34265255-AA329268-F748-4C0A-8889-5663F26D72D3 Q34563905-41660C31-3A89-4103-A715-CDFA4A23CC2A Q34581898-1F7EEFE3-1383-4455-A405-81FD90697CD8 Q35171679-B4DFEB58-5AAA-41C8-B7A1-550E47D76868 Q35197067-8A1AECEC-3068-4364-B8B7-B827BCB86F0E Q35224510-94081E72-5835-4F16-AFAD-5D1B354B3401 Q35467623-EE909246-EC9E-453C-82E8-4D2CEA0F7BA1 Q35600471-9BE1F978-94AD-43EF-84ED-A08EA82C622A Q35612116-A0E5D0CC-E106-4C73-A2B2-B73267797464 Q35799761-5AC40486-2C08-4681-AA37-0DE802B37B57 Q36515765-0C305B0D-F7FE-4C89-A962-243FD4647FF1 Q36736883-6A837CA7-A78F-4708-8075-3C8C3E9B9EB7 Q36814085-2A76C5FB-8DDF-4A18-A74C-A91F35077656 Q36843336-B5A8828C-9F8D-4B14-98AE-0B2592748BB8 Q37271062-A29ACBCF-71C4-4859-905E-0E824169E172 Q37357176-3640A52B-FC8A-4720-9671-46086DFAD670 Q37853403-905C0697-41BC-4C07-B21B-647669FF3532 Q37899201-4EEC559A-BB76-44EC-AABE-B2C559AC7684 Q38186099-0DCC012C-A9A2-4498-B5D8-70265E3AC7B2 Q38297505-2ECE9BF7-63C0-46AC-AABD-83BEEF6DB31E Q38297789-6E7C1230-4550-45AD-B6B8-241C0F91A3E7 Q38627361-0EF43107-94E5-47CE-B1CB-7387A9AB4425 Q38807488-F1B9B588-2331-424A-8E3E-3156DE6500EE Q40335473-D18D302B-4653-4CC8-896A-5B29A78B1A78 Q40512049-CE59A8AE-C231-4743-8A03-AA89ECA75FAC Q40626559-97E73BC5-8179-4641-8601-C0F2C49C231A Q41197625-60D23A9A-F7F3-43EB-A5A9-59B7649ED644 Q42800361-8BFE491C-2AEB-488A-9668-4D117DAC1922 Q42860196-7C7FD82D-CA9F-46E7-ADFC-CEDC05A93BCC

P2860

Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen

http://www.wikidata.org/entity/Q34622938

description

1987 nî lūn-bûn

@nan

1987 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Partial amino acid sequence of apolipoprotein

@nl

Partial amino acid sequence of ...... t is homologous to plasminogen

@ast

Partial amino acid sequence of ...... t is homologous to plasminogen

@en

type

label

Partial amino acid sequence of apolipoprotein

@nl

Partial amino acid sequence of ...... t is homologous to plasminogen

@ast

Partial amino acid sequence of ...... t is homologous to plasminogen

@en

prefLabel

Partial amino acid sequence of apolipoprotein

@nl

Partial amino acid sequence of ...... t is homologous to plasminogen

@ast

Partial amino acid sequence of ...... t is homologous to plasminogen

@en

P1433

Q34622938-9172B9A9-D7DD-4BF3-9AFD-717ABC830110

P1476

Q34622938-2B205C01-5CE0-470D-AA1E-7C887FAD4063

P2093

Q34622938-279F58CF-EB81-4A49-B307-9C59D4FC6348

Q34622938-27C21D10-F737-4AE3-865E-479E61251EB4

Q34622938-6A79F575-C6EE-4E24-BE70-546C6429FA21

Q34622938-938530A7-3E35-43BA-87C6-CA3F1AFEE369

Q34622938-A4F696C6-F294-4BA9-99D0-0780F2A245C3

Q34622938-A9704082-D774-46E9-9B22-5A1FE1EF0524

Q34622938-B9FCE1DD-31BC-4BC3-B98D-627512E4543D

Q34622938-F9CA0DA4-D306-4B76-AEBD-E477440E8755

P2860

Q34622938-26718A86-C90A-4082-B4B9-11ECDF9A1B32

Q34622938-397577AB-23C5-474B-A0C4-14E183FB6786

Q34622938-796D0F22-58C9-4C68-9C2D-C9E7AB389B62

Q34622938-7A0B236B-3A23-452C-9F8E-B48211B46270

Q34622938-AAC784A9-3BF7-4062-90C3-EDAE6D969CFA

Q34622938-AC6FAF7E-C177-4A8B-80CD-D845BDFF6261

Q34622938-ACC14321-D39D-49F7-A873-2646075911E3

Q34622938-B5E600DD-BDE1-4E8E-A4E1-9B8693ACD999

Q34622938-C5BA3EF9-5D7A-4C28-9AA5-155434AB9F27

P304

Q34622938-0E3413DF-FD70-416E-9525-294B69D16063

P31

Q34622938-8A43F223-9851-4B48-8C76-1F6C4956A4BB

P356

Q34622938-5EA642EA-B902-49CE-8013-FDB01B85FBA5

P407

Q34622938-03315C53-CADD-41F5-AFA8-A7DDC676712B

P433

Q34622938-FEC0B527-E514-4B83-B8D4-76B81ED5BCD4

P478

Q34622938-67F04D34-89FC-43B5-838E-A1EC4A38B1B1

P577

Q34622938-B1461DB3-95A3-4357-8C7B-03D58E32517C

P5875

Q34622938-815EFFFD-7825-4900-9658-9CAD24E3FBBD

P698

Q34622938-FEE588F9-7B90-44F1-8171-98C1A3FF0312

P932

Q34622938-80B70EB1-1BDC-4F25-B14F-94B1094F55CC

P356

PNAS.84.10.3224

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Partial amino acid sequence of ...... t is homologous to plasminogen

@en

P2093

A M Scanu

http://www.w3.org/2001/XMLSchema#string

C G Miller

http://www.w3.org/2001/XMLSchema#string

D L Eaton

http://www.w3.org/2001/XMLSchema#string

G M Fless

http://www.w3.org/2001/XMLSchema#string

J W McLean

http://www.w3.org/2001/XMLSchema#string

Q T Xu

http://www.w3.org/2001/XMLSchema#string

R M Lawn

http://www.w3.org/2001/XMLSchema#string

W J Kohr

http://www.w3.org/2001/XMLSchema#string

P2860

Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization.

Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa.

On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.

Lp(a) lipoprotein/pre-beta1-lipoprotein in Swedish middle-aged males and in patients with coronary heart disease.

Radioimmunoassay of human plasma Lp(a) lipoprotein.

The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin.

Isolation of apolipoprotein(a) from lipoprotein(a).

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

P304

3224-3228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.84.10.3224

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

1987-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19684546

http://www.w3.org/2001/XMLSchema#string

P698

3472206

http://www.w3.org/2001/XMLSchema#string

P932

304841

http://www.w3.org/2001/XMLSchema#string